Literature DB >> 12850260

Food vacuole plasmepsins are processed at a conserved site by an acidic convertase activity in Plasmodium falciparum.

Ritu Banerjee1, Susan E Francis, Daniel E Goldberg.   

Abstract

Intraerythrocytic Plasmodium falciparum digests vast amounts of hemoglobin within an acidic food vacuole (FV). Four homologous aspartic proteases participate in hemoglobin degradation within the FV. Plasmepsin (PM) I and II are thought to initiate degradation of the native hemoglobin molecule. PM IV and histo-aspartic protease (HAP) act on denatured globin further downstream in the pathway. PM I and II have been shown to be synthesized as zymogens and activated by proteolytic removal of a propiece. In this study, we have determined that the proteolytic processing of FV plasmepsins occurs immediately after a conserved Leu-Gly dipeptidyl motif with uniform kinetics and pH and inhibitor sensitivities. We have developed a cell-free in vitro processing assay that generates correctly processed plasmepsins. Our data suggest that proplasmepsin processing is not autocatalytic, but rather is mediated by a separate processing enzyme. This convertase requires acidic conditions and is blocked only by the calpain inhibitors, suggesting that it may be an atypical calpain-like protease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850260     DOI: 10.1016/s0166-6851(03)00119-1

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  17 in total

1.  Unraveling the ubiquitome of the human malaria parasite.

Authors:  Nadia Ponts; Anita Saraf; Duk-Won D Chung; Alona Harris; Jacques Prudhomme; Michael P Washburn; Laurence Florens; Karine G Le Roch
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites.

Authors:  Puran S Sijwali; Kentaro Kato; Karl B Seydel; Jiri Gut; Julie Lehman; Michael Klemba; Daniel E Goldberg; Louis H Miller; Philip J Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-27       Impact factor: 11.205

3.  Plasmodium food vacuole plasmepsins are activated by falcipains.

Authors:  Mark E Drew; Ritu Banerjee; Eric W Uffman; Scott Gilbertson; Philip J Rosenthal; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2008-02-28       Impact factor: 5.157

Review 4.  Malaria parasite plasmepsins: More than just plain old degradative pepsins.

Authors:  Armiyaw S Nasamu; Alexander J Polino; Eva S Istvan; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2020-05-04       Impact factor: 5.157

5.  Modeling and resistant alleles explain the selectivity of antimalarial compound 49c towards apicomplexan aspartyl proteases.

Authors:  Budhaditya Mukherjee; Francesca Tessaro; Juha Vahokoski; Inari Kursula; Jean-Baptiste Marq; Leonardo Scapozza; Dominique Soldati-Favre
Journal:  EMBO J       Date:  2018-03-08       Impact factor: 11.598

Review 6.  Structural studies of vacuolar plasmepsins.

Authors:  Prasenjit Bhaumik; Alla Gustchina; Alexander Wlodawer
Journal:  Biochim Biophys Acta       Date:  2011-04-20

7.  Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum.

Authors:  Puran S Sijwali; Philip J Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

8.  Apical surface expression of aspartic protease Plasmepsin 4, a potential transmission-blocking target of the plasmodium ookinete.

Authors:  Fengwu Li; Kailash P Patra; Charles A Yowell; John B Dame; Karen Chin; Joseph M Vinetz
Journal:  J Biol Chem       Date:  2010-01-07       Impact factor: 5.157

9.  Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.

Authors:  Pedro A Moura; John B Dame; David A Fidock
Journal:  Antimicrob Agents Chemother       Date:  2009-09-14       Impact factor: 5.191

10.  A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress.

Authors:  Paco Pino; Reto Caldelari; Budhaditya Mukherjee; Juha Vahokoski; Natacha Klages; Bohumil Maco; Christine R Collins; Michael J Blackman; Inari Kursula; Volker Heussler; Mathieu Brochet; Dominique Soldati-Favre
Journal:  Science       Date:  2017-10-27       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.